摘要
目的探讨胺碘酮联合硫酸镁治疗顽固性室性心律失常的临床疗效。方法将该院2009～2011年间收治的86例顽固性室性心律失常患者随机分为观察组和对照组,每组各43例,对照组患者给予胺碘酮治疗,观察组患者给予胺碘酮联合硫酸镁治疗,观察两组患者的临床疗效。结果观察组患者治疗总有效率为93.0%,显著高于对照组的72.1%,两组比较差异有统计学意义(P<0.05)。观察组患者治疗后不良反应发生率为7.0%,对照组患者治疗后不良反应发生率为4.7%,两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论采用胺碘酮联合硫酸镁治疗顽固性室性心律失常临床疗效确切,不良反应发生率低,值得临床进一步推广使用。
Objective To investigate the clinical curative effect of amiodarone combined with magnesium sulfate in the treatment of intractable ventricular arrhythmia.M ethods 86 cases of intractable ventricular arrhythmia in our hospital from 2009 to 2011 years were randomly divided into observation group and control group,43 cases in each group,patients in control group were treated by amiodarone,the patients in observation group were treated by amiodarone combined with magnesium sulfate,observed clinical curative effect of two groups.Results Total effective rate of patients in observation group was 93%,significantly higher than that in control group 72.1%,the difference between two groups was statistically significant（P0.05）.The adverse reaction rate of patients in observation group was 7%,the adverse reaction rate of patients in control group was 4.7%,the difference was not statistically significant（P0.05）.Conclusion Taking amiodarone combined with magnesium sulfate in the treatment of intractable ventricular arrhythmia has good clinical curative effect,and has a low incidence of adverse reactions,worthy of further clinical using.
出处
《中外医疗》
2013年第9期7-7,9,共2页
China & Foreign Medical Treatment
关键词
顽固性室性心律失常
胺碘酮
硫酸镁
临床疗效
Intractable ventricular arrhythmia
Amiodarone
Magnesium sulfate
Clinical curative effect
